Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Prescribing Opioid Replacement Therapy in U.S. Correctional Settings.

Farahmand P, Modesto-Lowe V, Chaplin MM.

J Am Acad Psychiatry Law. 2017 Dec;45(4):472-477.

PMID:
29282239
2.

Use and misuse of opioid agonists in opioid addiction.

Modesto-Lowe V, Swiezbin K, Chaplin M, Hoefer G.

Cleve Clin J Med. 2017 May;84(5):377-384. doi: 10.3949/ccjm.84a.16091. Review.

3.

E-cigs . . . Are They Cool? Talking to Teens About E-Cigarettes.

Modesto-Lowe V, Alvarado C.

Clin Pediatr (Phila). 2017 Sep;56(10):947-952. doi: 10.1177/0009922817705188. Epub 2017 Apr 26. Review.

PMID:
28443340
4.

Clinical Implications of Emotion Dysregulation in ADHD.

Modesto-Lowe V, Alvarado C, Choi C.

Conn Med. 2017 Jan;81(1):13-18.

PMID:
29782760
5.

Psychotherapy for Adolescents With Attention-Deficit Hyperactivity Disorder: A Pediatrician's Guide.

Modesto-Lowe V, Charbonneau V, Farahmand P.

Clin Pediatr (Phila). 2017 Jun;56(7):667-674. doi: 10.1177/0009922816673308. Epub 2016 Nov 27. Review.

PMID:
27895149
6.

The Opioid Crisis and the Physician's Role in Contributing to its Resolution: Step One--Prevention of Overdoses.

Wolfe S, Bouffard DL, Modesto-Lowe V.

Conn Med. 2016 Jun-Jul;80(6):325-34. Review.

PMID:
27509638
7.

Improving Treatment in Minority Children With Attention Deficit/Hyperactivity Disorder.

Alvarado C, Modesto-Lowe V.

Clin Pediatr (Phila). 2017 Feb;56(2):171-176. doi: 10.1177/0009922816645517. Epub 2016 Jul 20. Review.

PMID:
27113035
8.

Does mindfulness meditation improve attention in attention deficit hyperactivity disorder?

Modesto-Lowe V, Farahmand P, Chaplin M, Sarro L.

World J Psychiatry. 2015 Dec 22;5(4):397-403. doi: 10.5498/wjp.v5.i4.397. eCollection 2015 Dec 22. Review.

9.

Universal precautions to reduce stimulant misuse in treating adult ADHD.

Modesto-Lowe V, Chaplin M, Sinha S, Woodard K.

Cleve Clin J Med. 2015 Aug;82(8):506-12. doi: 10.3949/ccjm.82a.14131. Review.

10.

Parenting teens with attention-deficit/hyperactivity disorder: challenges and opportunities.

Modesto-Lowe V, Chaplin M, Godsay V, Soovajian V.

Clin Pediatr (Phila). 2014 Sep;53(10):943-8. doi: 10.1177/0009922814540984. Epub 2014 Jun 30.

PMID:
24982442
11.

Are motivation deficits underestimated in patients with ADHD? A review of the literature.

Modesto-Lowe V, Chaplin M, Soovajian V, Meyer A.

Postgrad Med. 2013 Jul;125(4):47-52. doi: 10.3810/pgm.2013.07.2677. Review.

PMID:
23933893
12.

Coping with urges to smoke: what is a clinician to do?

Modesto-Lowe V, Chmielewska A.

Conn Med. 2013 May;77(5):289-94. Review.

PMID:
23777042
13.

A clinican's guide to adult attention-deficit hyperactivity disorder.

Modesto-Lowe V, Meyer A, Soovajian V.

Conn Med. 2012 Oct;76(9):517-23. Review.

PMID:
23155670
14.

Cancer pain in the opioid-addicted patient: can we treat it right?

Modesto-Lowe V, Girard L, Chaplin M.

J Opioid Manag. 2012 May-Jun;8(3):167-75. doi: 10.5055/jom.2012.0113. Review.

PMID:
22798177
15.

Attention-deficit/hyperactivity disorder: a shift toward resilience?

Modesto-Lowe V, Yelunina L, Hanjan K.

Clin Pediatr (Phila). 2011 Jun;50(6):518-24. doi: 10.1177/0009922810394836. Epub 2011 Jan 23.

PMID:
21262756
16.

Can we prevent smoking in children with ADHD: a review of the literature.

Modesto-Lowe V, Danforth JS, Neering C, Easton C.

Conn Med. 2010 Apr;74(4):229-36. Review.

PMID:
20441004
17.

Methadone deaths: risk factors in pain and addicted populations.

Modesto-Lowe V, Brooks D, Petry N.

J Gen Intern Med. 2010 Apr;25(4):305-9. doi: 10.1007/s11606-009-1225-0. Epub 2010 Jan 20. Review.

18.

Divided doses for methadone maintenance.

Modesto-Lowe V.

Am J Psychiatry. 2008 Oct;165(10):1358; author reply 1358-9. doi: 10.1176/appi.ajp.2008.08040586. No abstract available.

PMID:
18829892
19.

The conduct disorder-alcohol link: implications for prevention strategies.

Modesto-Lowe V.

Pediatrics. 2008 Jul;122(1):209; author reply 209-10. doi: 10.1542/peds.2008-0777. No abstract available.

PMID:
18596008
20.

ADHD: does parenting style matter?

Modesto-Lowe V, Danforth JS, Brooks D.

Clin Pediatr (Phila). 2008 Nov;47(9):865-72. doi: 10.1177/0009922808319963. Epub 2008 Jun 16. Review.

PMID:
18559885
21.

Intervening early to reduce developmentally harmful substance use among youth populations.

Modesto-Lowe V, Petry NM, McCartney M.

Med J Aust. 2008 Apr 21;188(8):494-5. No abstract available.

PMID:
18429731
22.

[Ludomania: cross-cultural examinations of gambling and its treatment].

Weinstock J, Ledgerwood DM, Modesto-Lowe V, Petry NM.

Rev Bras Psiquiatr. 2008 May;30 Suppl 1:S3-S10. Epub 2008 Jan 31. Review. Portuguese.

23.

Pain management in patients with substance abuse: treatment challenges for pain and addiction specialists.

Modesto-Lowe V, Johnson K, Petry NM.

Am J Addict. 2007 Sep-Oct;16(5):424-5. No abstract available.

PMID:
17882615
24.

Addiction and chronic pain: diagnostic and treatment dilemmas.

Modesto-Lowe V, Brooks D, Freedman K, Hargus E.

Conn Med. 2007 Mar;71(3):139-44.

PMID:
17405395
25.

Alcohol dependence and suicidal behavior: from research to clinical challenges.

Modesto-Lowe V, Brooks D, Ghani M.

Harv Rev Psychiatry. 2006 Sep-Oct;14(5):241-8. Review.

PMID:
16990169
26.

The opioidergic-alcohol link : implications for treatment.

Modesto-Lowe V, Fritz EM.

CNS Drugs. 2005;19(8):693-707. Review.

PMID:
16097851
27.

Alcohol withdrawal kindling: is there a role for anticonvulsants?

Modesto-Lowe V, Huard J, Conrad C.

Psychiatry (Edgmont). 2005 May;2(5):25-31.

28.

Nefazodone treatment of comorbid alcohol dependence and major depression.

Hernandez-Avila CA, Modesto-Lowe V, Feinn R, Kranzler HR.

Alcohol Clin Exp Res. 2004 Mar;28(3):433-40.

PMID:
15084901
29.

Recognition and treatment of alcohol use disorders in US jails.

Modesto-Lowe V, Fritz EM.

Psychiatr Serv. 2003 Oct;54(10):1413-4. No abstract available.

PMID:
14557534
30.

Effects of rapid tryptophan depletion on mood and urge to drink in patients with co-morbid major depression and alcohol dependence.

Pierucci-Lagha A, Feinn R, Modesto-Lowe V, Swift R, Nellissery M, Covault J, Kranzler HR.

Psychopharmacology (Berl). 2004 Jan;171(3):340-8. Epub 2003 Sep 10.

PMID:
13680073
31.

Naltrexone depot (DrugAbuse Sciences).

Modesto-Lowe V.

IDrugs. 2002 Aug;5(8):835-8.

PMID:
12802700
32.

Illy users in Connecticut: two case reports.

Modesto-Lowe V.

Subst Abus. 2002 Dec;23(4):255-7. No abstract available.

PMID:
12438838
33.

Clinical uses of naltrexone: a review of the evidence.

Modesto-Lowe V, Van Kirk J.

Exp Clin Psychopharmacol. 2002 Aug;10(3):213-27. Review.

PMID:
12233982
34.

Recognizing and managing "illy" intoxication.

Modesto-Lowe V, Petry NM.

Psychiatr Serv. 2001 Dec;52(12):1660. No abstract available.

PMID:
11726765
35.

Using cue reactivity to evaluate medications for treatment of cocaine dependence: a critical review.

Modesto-Lowe V, Kranzler HR.

Addiction. 1999 Nov;94(11):1639-51. Review.

PMID:
10892004
36.

Diagnosis and treatment of alcohol-dependent patients with comorbid psychiatric disorders.

Modesto-Lowe V, Kranzler HR.

Alcohol Res Health. 1999;23(2):144-9. Review.

PMID:
10890809
37.

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

Kranzler HR, Modesto-Lowe V, Van Kirk J.

Neuropsychopharmacology. 2000 May;22(5):493-503.

38.

Pharmacologic treatments for drug and alcohol dependence.

Kranzler HR, Amin H, Modesto-Lowe V, Oncken C.

Psychiatr Clin North Am. 1999 Jun;22(2):401-23. Review.

PMID:
10385941
39.

Validity of the Obsessive Compulsive Drinking Scale (OCDS): does craving predict drinking behavior?

Kranzler HR, Mulgrew CL, Modesto-Lowe V, Burleson JA.

Alcohol Clin Exp Res. 1999 Jan;23(1):108-14.

PMID:
10029210
40.

PROP taster status and parental history of alcohol dependence.

Kranzler HR, Skipsey K, Modesto-Lowe V.

Drug Alcohol Depend. 1998 Oct 1;52(2):109-13.

PMID:
9800140
41.

Sustained-release naltrexone for alcoholism treatment: a preliminary study.

Kranzler HR, Modesto-Lowe V, Nuwayser ES.

Alcohol Clin Exp Res. 1998 Aug;22(5):1074-9.

PMID:
9726277
42.

Effects of naltrexone on cue-elicited craving for alcohol and cocaine.

Modesto-Lowe V, Burleson JA, Hersh D, Bauer LO, Kranzler HR.

Drug Alcohol Depend. 1997 Dec;49(1):9-16.

PMID:
9476694

Supplemental Content

Loading ...
Support Center